Assenagon Asset Management S.A. Paratek Pharmaceuticals, Inc. Transaction History

Assenagon Asset Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$1.37 - $2.54 $324,657 - $601,919	236,976 Added 180.53%	368,240 $935,000
Q4 2022 Jan 12, 2023	SELL	$1.67 - $2.51 $138,845 - $208,683	-83,141 Reduced 38.78%	131,264 $245,000
Q3 2022 Oct 27, 2022	BUY	$1.96 - $2.93 $235,970 - $352,751	120,393 Added 128.06%	214,405 $551,000
Q2 2022 Jul 27, 2022	BUY	$1.73 - $3.09 $162,640 - $290,497	94,012 New	94,012 $181,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.